← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE AND ZIDOVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2015-09-17

Drug application

FDA Application #

ANDA079124

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMIVUDINE AND ZIDOVUDINE

Generic name

LAMIVUDINE AND ZIDOVUDINE

Active ingredients

LAMIVUDINE; ZIDOVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2015-09-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown